2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+‐dependent and ‐independent mechanisms

@article{Kondo19982ArachidonoylglycerolAE,
  title={2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+‐dependent and ‐independent mechanisms},
  author={S. Kondo and H. Kondo and S. Nakane and T. Kodaka and A. Tokumura and K. Waku and T. Sugiura},
  journal={FEBS Letters},
  year={1998},
  volume={429}
}
  • S. Kondo, H. Kondo, +4 authors T. Sugiura
  • Published 1998
  • Chemistry, Medicine
  • FEBS Letters
  • The molecular species compositions of monoacylglycerols obtained from various rat tissues were examined by reverse‐phase high‐performance liquid chromatography (HPLC) and gas chromatography‐mass spectrometry (GC‐MS) analyses. We confirmed that 2‐arachidonoylglycerol, an endogenous cannabinoid receptor agonist, is one of the most abundant molecular species of monoacylglycerols in the brain. Substantial amounts of 2‐arachidonoylglycerol were also found in the liver, spleen, lung and kidney, but… CONTINUE READING
    141 Citations
    Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
    • 285
    • PDF

    References

    SHOWING 1-10 OF 30 REFERENCES
    2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
    • 1,851